Cancer-associated retinopathy secondary to gallbladder carcinoma
GMS Ophthalmology Cases · 23.09.2024 · 14 (Doc11) · Doc11-Doc11
DOI: 10.3205/oc000243 ↗Kurz gefasst
Fallbericht in der Zeitschrift GMS Ophthalmology Cases, erschienen am 23.09.2024. Verfasst von Karel Goyvaerts und 3 weiteren Autor:innen. Beteiligte Einrichtung: Antwerp University Hospital, Department of Ophthalmology, Edegem, Belgium. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To present a rare case of cancer-associated retinopathy secondary to gallbladder carcinoma.
Methods
Retrospective case report. Drugs used in case report: methylprednisolone (Medrol), CAS number: 83-43-2, producer: Pfizer; carboplatin, CAS number: 41575-94-4, producer: Accor; etoposide, CAS number: 33419-42-0, producer: Teva; methotrexate (Ledertrexate), CAS number: 59-05-2, producer: Pfizer.
Results
A 57-year-old Moroccan man was referred with bilateral progressive vision loss in the last 4 months. At presentation, best corrected visual acuity (BCVA) was counting fingers for the right eye and 20/500 for the left eye. Examination demonstrated signs of vitritis, an electronegative full-field electroretinography (FF-ERG), ocular coherence tomography (OCT) abnormalities and multiple hyperautofluorescent round lesions on fundus autofluorescence imaging (FAF). The diagnosis of cancer-associated retinopathy (CAR) was considered, thus a positron emission tomography-computed tomography (PET-CT) was performed and revealed the presence of a metastasized gallbladder carcinoma. Additional fluorescence in situ hybridization (FISH) showed seropositivity for anti-retinal autoantibodies. High-dose corticosteroids together with anti-tumoral medication (carboplatin-etoposide) gradually improved the BCVA to 20/66 for the right eye and 20/20 for the left eye.
Conclusions
Consider the diagnosis of CAR in patients with progressive concentric visual field loss, uveitis and fundus abnormalities, especially if bilateral. If CAR is suspected, perform a full work-up: FF-ERG, OCT, and whole-body PET-CT. In the treatment of CAR, immunosuppressives are mostly used, combined with antitumoral therapy. However, in the long-term, progressive visual loss is expected in most cases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Antwerp University Hospital, Department of Ophthalmology, Edegem, Belgium.
- ZNA Middelheim Hospital Antwerp, Department of Ophthalmology, Antwerp, Belgium.
- Brussels University Hospital, Department of Ophthalmology, Jette, Belgium.
Zitieren
APA
Goyvaerts, K., Coeckelbergh, T., Schauwvlieghe, P. P., & van Lint, M. (2024). Cancer-associated retinopathy secondary to gallbladder carcinoma. GMS Ophthalmology Cases, 14(Doc11), Doc11-Doc11. https://doi.org/10.3205/oc000243
Vancouver
Goyvaerts K, Coeckelbergh T, Schauwvlieghe PP, van Lint M. Cancer-associated retinopathy secondary to gallbladder carcinoma. GMS Ophthalmology Cases. 2024;14(Doc11):Doc11-Doc11. doi:10.3205/oc000243
BibTeX
@article{Goyvaerts2024,
author = {Goyvaerts, Karel and Coeckelbergh, Tanja and Schauwvlieghe, Pieter-Paul and van Lint, Michel},
title = {Cancer-associated retinopathy secondary to gallbladder carcinoma},
journal = {GMS Ophthalmology Cases},
year = {2024},
volume = {14},
number = {Doc11},
pages = {Doc11--Doc11},
doi = {10.3205/oc000243}
}
EUVIMED